Table 2.
Management of gait dysfunction in PSP/CBS.
| 1. Pharmacologic therapy |
| a. Amantadine |
| i. Start at 50–100 mg daily and titrate at intervals of at least 2 weeks |
| ii. Do not exceed 100 mg TID. |
| iii. Monitor for psychosis, confusion, and constipation. |
| iv. Inspect for livedo reticularis and reassure patient that it is benign. |
| b. Coenzyme Q-10 |
| i. Modest benefit on average but some patients respond well |
| ii. Use liposomal form (a liquid) at 100 mg TID |
| iii. If no benefit after 2 months, discontinue. |
| 2. Non-pharmacologic therapy |
| a. Physical therapy |
| i. Early intervention recommended |
| ii. Focused on postural stability and gait re-training |
| iii. Balance, eye movement training and visual awareness training may help. |
| b. Exercise |
| i. Aerobic exercise |
| 1. If tolerated and safe |
| 2. Obtain approval from PCP or cardiologist if cardiovascular history is present. |
| ii. Recumbent bicycle is recommended. |
| c. Assistive devices |
| i. Cane should be prescribed with caution |
| 1. Tripping hazard, as patients tend to carry cane hanging from wrist |
| 2. Fails to prevent falls in other directions. |
| ii. Weighted walker |
| iii. Wheelchair |
| iv. A lightweight transport wheelchair is useful when the caregiver cannot lift a standard wheelchair into a car's trunk. |